A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine |
| |
| Institution: | 1. Indiana University Fairbanks School of Public Health, Department of Epidemiology, 1050 Wishard Blvd, RG5, Indianapolis, IN 46202, USA;2. Indiana University School of Medicine, Department of Pediatrics, 410 W 10th Street Suite 1001, Indianapolis, IN 46202, USA;3. Regenstrief Institute, Inc., Center for Biomedical Informatics, 1101 W. 10th St., Indianapolis, IN 46202, USA;4. Center for Health Information and Communication Department of Veterans Affairs Veterans Health Administration Health Services Research and Development Service, CIN 13-416 1481 W. 10th St, 11H, Indianapolis, IN 46202, USA;5. Merck & Co., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA;1. Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215, USA;2. Department of Community Health, Tufts University, 574 Boston Avenue, Suite 208, Medford, MA 02155, USA;1. Children''s Outcomes Research Program , Children''s Hospital Colorado, Aurora, CO;2. Department of Pediatrics , Colorado School of Public Health , Colorado Health Outcomes Program , University of Colorado Anschutz Medical Campus, Aurora, CO;3. National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention , National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention, Atlanta, GA;4. Division of General Internal Medicine , Denver Health, Denver, CO;1. Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL;2. Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL |
| |
| Abstract: | The 9-valent Human Papillomavirus (HPV) vaccine, 9vHPV, was licensed in the U.S. in December, 2014. We assessed healthcare provider (HCP) awareness of the newly approved vaccine and identified questions HCPs have about the vaccine. As part of a larger study, we used semi-structured interviews to ask 22 pediatric HCPs about their awareness of 9vHPV, questions they have about the vaccine, and questions they anticipate from patients and parents. Interviews were audio-recorded and transcribed then analyzed using inductive content analysis. Over half were aware of the vaccine but few HCPs claimed to be familiar with it. HCPs indicated several questions with common themes pertaining to efficacy, side effects, and cost. Only half of HCPs believed patients or parents would have questions. The results suggest strategies and areas for health systems and public health organizations to target in order to resolve unmet educational needs among HCPs regarding 9vHPV. |
| |
| Keywords: | HPV Awareness Healthcare provider Vaccine Sexually transmitted infection Education |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
